Jasper Therapeutics, Inc.
JSPR
$5.41
$0.030.56%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.32M | -18.64M | -14.58M | -13.73M | -16.58M |
| Total Depreciation and Amortization | 245.00K | 541.00K | 299.00K | 288.00K | 283.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.11M | 2.10M | 1.60M | 1.31M | 1.24M |
| Change in Net Operating Assets | 831.00K | 1.94M | 1.00M | -3.60M | -1.42M |
| Cash from Operations | -21.13M | -14.05M | -11.68M | -15.74M | -16.48M |
| Capital Expenditure | -96.00K | -274.00K | -157.00K | -25.00K | -230.00K |
| Sale of Property, Plant, and Equipment | 20.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -76.00K | -274.00K | -157.00K | -25.00K | -230.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 345.00K | 9.00K | 181.00K | 47.35M | 28.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -299.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 345.00K | 9.00K | 181.00K | 47.35M | -271.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.87M | -14.32M | -11.66M | 31.59M | -16.98M |